Free Trial

UnitedHealth Group (UNH) Stock Forecast & Price Target

$559.58
+4.88 (+0.88%)
(As of 07/24/2024 ET)

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 20 Wall Street analysts who have issued ratings for UnitedHealth Group in the last 12 months, the stock has a consensus rating of "Buy." Out of the 20 analysts, 1 has given a hold rating, 18 have given a buy rating, and 1 has given a strong buy rating for UNH.

Consensus Price Target

$614.17
9.75% Upside
High Forecast$680.00
Average Forecast$614.17
Low Forecast$559.00

According to the 20 analysts' twelve-month price targets for UnitedHealth Group, the average price target is $614.17. The highest price target for UNH is $680.00, while the lowest price target for UNH is $559.00. The average price target represents a forecasted upside of 9.75% from the current price of $559.58.

TypeCurrent Forecast
7/26/23 to 7/25/24
1 Month Ago
6/26/23 to 6/25/24
3 Months Ago
4/27/23 to 4/26/24
1 Year Ago
7/26/22 to 7/26/23
Consensus Rating
Buy
Moderate Buy
Moderate Buy
Buy
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
18 Buy rating(s)
17 Buy rating(s)
15 Buy rating(s)
14 Buy rating(s)
Hold
1 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$614.17$579.74$570.05$579.89
Forecasted Upside9.75% Upside18.45% Upside17.52% Upside17.88% Upside
Get UnitedHealth Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for UNH and its competitors with MarketBeat's FREE daily newsletter.

UNH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

UNH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

UnitedHealth Group Stock vs. The Competition

TypeUnitedHealth GroupMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.72
2.51
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside9.75% Upside3,260.71% Upside10.67% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/23/2024Cantor Fitzgerald
3 of 5 stars
 Reiterated RatingOverweight ➝ Overweight$591.00 ➝ $591.00+6.20%
7/18/2024HSBC
2 of 5 stars
 Boost Target$580.00 ➝ $610.00+7.68%
7/18/2024UBS Group
3 of 5 stars
 Boost TargetBuy ➝ Buy$640.00 ➝ $680.00+20.90%
7/17/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Toung
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$570.00 ➝ $600.00+4.95%
7/17/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$546.00 ➝ $601.00+5.51%
7/17/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$560.00 ➝ $604.00+6.30%
7/17/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$525.00 ➝ $630.00+11.23%
7/17/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$555.00 ➝ $615.00+8.86%
7/17/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$595.00 ➝ $615.00+12.05%
7/17/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$597.00 ➝ $640.00+16.60%
7/17/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$600.00 ➝ $640.00+16.60%
7/17/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$481.00 ➝ $647.00+17.88%
5/30/2024Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/30/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$546.00 ➝ $559.00+15.75%
4/19/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$545.00 ➝ $562.00+13.96%
4/17/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$566.00 ➝ $571.00+18.76%
3/13/2024Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold
3/7/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$675.00+42.83%
2/8/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$605.00+16.37%
1/17/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$610.00+15.23%
7/18/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$595.00 ➝ $603.00+24.55%
7/11/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$600.00 ➝ $549.00+18.56%
6/14/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$625.00 ➝ $560.00+13.98%
4/17/2023Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$590.00 ➝ $600.00+17.24%
4/14/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingStrong-Buy$630.00+24.75%
12/7/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$590.00 ➝ $610.00+13.11%
10/17/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$625.00 ➝ $618.00+20.44%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 08:57 AM ET.

UNH Forecast - Frequently Asked Questions

What is UnitedHealth Group's forecast for 2024?

According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for UnitedHealth Group is $614.17, with a high forecast of $680.00 and a low forecast of $559.00.

Should I buy or sell UnitedHealth Group stock right now?

20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last year. There is currently 1 hold rating, 18 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" UNH shares.

Does UnitedHealth Group's stock price have much upside?

According to analysts, UnitedHealth Group's stock has a predicted upside of 14.32% based on their 12-month stock forecasts.

Has UnitedHealth Group been upgraded by Wall Street analysts recently?

Over the previous 90 days, UnitedHealth Group's stock had 3 upgrades by analysts.

What analysts cover UnitedHealth Group?
Do Wall Street analysts like UnitedHealth Group more than its competitors?

Analysts like UnitedHealth Group more than other "medical" companies. The consensus rating for UnitedHealth Group is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how UNH compares to other companies.


This page (NYSE:UNH) was last updated on 7/25/2024 by MarketBeat.com Staff

From Our Partners